John Canepa, Chief Financial Officer
John was a member of the team that acquired Asterand Bioscience Inc. in the fall of 2012 and leads the Company’s business activities. Mr. Canepa began his professional career spending 23 years in the Boston office of Arthur Andersen where he was an audit partner working primarily with technology-based companies. He was also in charge of the firm’s worldwide life science practice. John left Anderson in 2001 and entered the entrepreneurial world. He has been CFO of Winphoria Networks, a telecommunications software company acquired by Motorola in 2003, and CEO of U.S. Genomics Inc. and PathoGenetix Inc. John has a BA from Denison University and an MBA from Michigan State University. Furthermore, he is on the board of directors of Harvard Apparatus Regenerative Technology and Chairman of the board of trustees of Mount Auburn Hospital.
Peter Ferrigno, Chief Commercial Officer
Peter joined Asterand Bioscience Inc. as Chief Commercial Officer in March 2013. His prior experience included 33 years working at Becton Dickinson (BD), a fortune 500 Global Medical Device Company. Over his BD career, Peter held senior level positions as General Manager, VP Sales and Marketing, VP Business Development, and VP Distribution Management. Peter worked across several BD businesses focused in clinical research, life sciences, pharmaceutical and diabetes care. His scope of responsibilities covered P&L, world-wide business development, channel management, and business strategy. Peter earned a Bachelor of Science degree in business economics/biology from Niagara University. In addition, he currently serves on the Board of Marist College School of Management and is an active contributing member of the Massachusetts Biotech council.
Amanda Woodrooffe, PhD, Vice President & General Manager, UK Operations
Amanda joined Asterand Bioscience Inc. in 2001 (then known as Pharmagene) and was appointed General Manager UK in 2010 with responsibility for leading the UK services business. Prior to her current role, Amanda was responsible for progressing Asterand Bioscience’s corporate development activities through researching, sourcing and prioritizing scientific opportunities and leading scientific diligence for M&A. Previously, Amanda was a Scientific Department Head responsible for delivery of client projects and for leading DMPK activities for Pharmagene’s internal drug discovery programs. Prior to joining Pharmagene, Amanda worked for 7 years at various Glaxo companies, where her research focused on the use of human in vitro approaches. Amanda holds PhD in in vitro drug-interactions from the University of Cambridge.
Shannon Richey, Vice President & General Manager, Detroit Operations
Shannon joined the Company in 2007 working primarily in Marketing and Commercial Operations. More recently, Shannon led Asterand Bioscience’s custom procurement business segment until 2015 when she was appointed to oversee the entire Detroit-based laboratory operations. Before joining Asterand Bioscience, Shannon held managerial and executive level positions within the life science and pharmaceutical industry. She has been a Director of Sales and Marketing at Assay Designs (Enzo Life Sciences), and EVP of Marketing at Genomic Solutions, where she was a member of the team that guided the Company through its IPO in 2000. She has also held managerial positions at Immuno US (Baxter Hyland) and Schering Plough. Shannon earned a BA from Wayne State University and an MBA from Cornell University.
Tony Brown, PhD, Vice President, Scientific and Corporate Development
Tony has been with Asterand Bioscience for 16 years. Prior to taking up his current position, he held a number of senior positions within the company including General Manager for the UK Services business and General Manager for the Detroit-based tissue products business. In addition, he was appointed VP, Strategic Alliances, with responsibility for securing and managing the Company’s human tissue supply collaborations. Tony began his career teaching physiology at Nottingham University Medical School in the UK after obtaining degrees in engineering, bioengineering and a PhD in physiology. He subsequently joined SmithKline Beecham in 1988, where he headed the receptor pharmacology group within neurosciences research and led several drug discovery projects and drug screening programs. Tony joined Pharmagene (now Asterand Bioscience) in 1998. Tony has published on the pharmacology and biochemistry of ion and neurotransmitter transport and on the use of human tissues for research in drug discovery and development.
Michael Button, Sr. Director of Supply Chain and Strategic Development
Michael has been with Asterand Bioscience since 2009 and is responsible for global purchasing, inventory control, and supplier management. He also leads the Company’s government initiatives with both The Cancer Genome Atlas Program and The Clinical Proteomic Tumor Analysis Consortium. Michael began his career at Dow Chemical where he worked in various supply chain capacities. After Dow, Michael spent two years at the global strategy firm, Bain & Company, working on strategic growth and profitability initiatives Later on, Michael left Bain to join ThyssenKrupp Materials NA (TKMNA) where he held multiple executive level positions spanning operations management, supply chain optimization, and mergers & acquisitions. Micheal joined Asterand Bioscience to enter the entrepreneurial world and to work in a new and emerging industry. Michael holds a BS from Purdue University and a MBA with Distinction from The Harvard Business School.
Cathie G. Miller, PhD, Director of Product Marketing
Cathie joined Asterand Bioscience Inc. in 2015 and is responsible for global product management and marketing activities. Before joining Asterand Bioscience, Inc., Cathie was the Global Product Manager for the Biobanking, Chromatography and various other product lines at WHEATON and Director of the Human Biological Data Interchange at the National Disease Research Interchange. Her research career extended for 20 years across immunology, virology and cancer therapeutics. Cathie holds a PhD in Microbiology and Immunology from the University of Louisville and completed her post-doctoral studies at the Wistar Institute and the University of Pennsylvania. She was also Director of the Gayle Helparin-Kahn Laboratory of Viral Onco-Therapeutics at Henry Ford Health System.
Pamela Filipowicz, Director Human Resources
Pam has been a part of the Asterand Bioscience team since 2009 and is responsible for the global human resources function. She has over 16 years of human resources experience including recruiting, performance management, career development, employee relations, benefits, compensation, employee engagement, payroll, and organizational change. Prior to joining Asterand Bioscience, Pam worked at PPOM, a Michigan based health network, and Aetna, Inc., one of the largest health networks in America. She supported over 600 employees at multiple sites across the US during her position at Aetna, Inc.
Pam gained significant expertise in benefits and employee relations, and was key to managing the business’s HR needs through several mergers and acquisitions while at these two organizations. Pam graduated with honors from Oakland University with a BA in history, and a minor in labor and employment studies. She is certified as a Senior Professional in Human Resources (SPHR), and is a member of the Society for Human Resource Management (SHRM).